US Patent Issued to BeOne Medicines I on July 14 for "Imidazotriazine and pyrrolopyrimidine derivatives as KRAS G12C inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,844, issued on July 14, was assigned to BeOne Medicines I GmbH (Basel, Switzerland).

"Imidazotriazine and pyrrolopyrimidine derivatives as KRAS G12C inhibitors" was invented by Guoliang Zhang (Beiging, China), Jianzhuang Miao (Beijing) and Ce Wang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are imidazotriazine and pyrrolopyrimidine derivatives or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof useful as a G12C inhibitors, and a pharmaceutical composition comprising the same. Also disclosed herein is a method of treating cancer using the imidazotriazine and pyrrolopyrimidine derivatives or a stereois...